Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,473–3,480 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Recursion Pharmaceuticals Inc. REC-4881 AXIN1 or APC Mutant Cancers Phase 2 Withdrawn Oral Oncology
Recursion Pharmaceuticals Inc. REC-3964 - (ALDER) Clostridium Difficile Infection Phase 2 Trial Planned Intravenous Gastroenterology
Recursion Pharmaceuticals Inc. REC-4881 - (TUPELO) Familial adenomatous polyposis (FAP) Phase 2 Data Released oral Genetic Disorder
Recursion Pharmaceuticals Inc. REC-994 - (SYCAMORE) Cerebral Cavernous Malformation (CCM) Phase 2a Trial Discontinued Oral Neurology
Redhill Biopharma Ltd. RHB-204 Nontuberculous mycobacteria (NTM) infections Phase 3 Ongoing Oral Antibiotic
Redhill Biopharma Ltd. RHB-104 MAP Crohn’s disease Phase 3 Trial Completed Oral Gastroenterology
Redhill Biopharma Ltd. BEKINDA Gastroenteritis Phase 3 Trial Completed Oral Gastroenterology
Redhill Biopharma Ltd. RHB-107 (upamostat) COVID-19 (outpatients) Phase 2/3 Looking for Funding oral COVID-19